Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.

Cancer Immunol Immunother · 2011 · PMC3119331 · PMID 21431917

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

not quite significantP = 0.056so close (0.05 < p ≤ 0.1)

A comparison of the weekly expansion of T cells of the groups of responder and non-responder patients clearly revealed that tumor-stimulated PBMC of the clinical responders expanded faster than those of the non-responders, albeit not quite significant ( P = 0.056; Fig. 2 ).

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.